|Poll|August 21, 2014

Mini-quiz: Electroencephalogram Abnormalities in Psychiatric Patients

Compared with healthy controls, is the prevalence of EEG abnormalities in psychiatric patients different than in healthy controls? Take the quiz and learn more.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Earn CME Credit With Psychiatric Times: Articles You Don’t Want to Miss

ByPsychiatric Times Editors

February 24th 2026

A Critical Catch: Catatonia Due to Multiple General Medical Conditions

ByErica Taylor, MD, MPH,Drew Cumming, MD,James A. Bourgeois, OD, MD

October 24th 2025

Dr Max Fink, Farewell and Thank You

ByHoracio A. Capote, MD

October 16th 2025

Addressing Cognition in Late-Life Depression

ByJoshua J. Hubregsen, MD,Andre R. Brunoni, MD, PhD,Molly E. Camp, MD,Tarek K. Rajji, MD

October 1st 2025

Dr Max Fink, Farewell and Thank You!

ByHoracio A. Capote, MD

August 27th 2025

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Mini-quiz: Electroencephalogram Abnormalities in Psychiatric Patients

Related Content

Earn CME Credit With Psychiatric Times: Articles You Don’t Want to Miss

A Critical Catch: Catatonia Due to Multiple General Medical Conditions

Dr Max Fink, Farewell and Thank You

Addressing Cognition in Late-Life Depression

Dr Max Fink, Farewell and Thank You!

Latest CME

Southern California Psychiatry Conference

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

“Engineered Addiction”: Redefining Addictive Disorders and the Psychiatric Impact of Social Media

New Positive Phase 2 Topline Data on Elunetirom for the Treatment of Bipolar Depression

Podcast: Early Intervention & Psychopharmacology in Bipolar Disorder With Robert M. Post, MD

Suicide Risk Assessment in Patients Denying Suicidal Intent

Predicting Relapse in Treatment-Resistant Depression: Findings From New Esketamine Analysis